1. Home
  2. CDNA vs DOMO Comparison

CDNA vs DOMO Comparison

Compare CDNA & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • DOMO
  • Stock Information
  • Founded
  • CDNA 1998
  • DOMO 2010
  • Country
  • CDNA United States
  • DOMO United States
  • Employees
  • CDNA N/A
  • DOMO N/A
  • Industry
  • CDNA Medical Specialities
  • DOMO Computer Software: Prepackaged Software
  • Sector
  • CDNA Health Care
  • DOMO Technology
  • Exchange
  • CDNA Nasdaq
  • DOMO Nasdaq
  • Market Cap
  • CDNA 712.2M
  • DOMO 707.1M
  • IPO Year
  • CDNA 2014
  • DOMO 2018
  • Fundamental
  • Price
  • CDNA $14.49
  • DOMO $13.08
  • Analyst Decision
  • CDNA Buy
  • DOMO Buy
  • Analyst Count
  • CDNA 8
  • DOMO 8
  • Target Price
  • CDNA $26.86
  • DOMO $15.13
  • AVG Volume (30 Days)
  • CDNA 951.2K
  • DOMO 634.9K
  • Earning Date
  • CDNA 11-04-2025
  • DOMO 12-04-2025
  • Dividend Yield
  • CDNA N/A
  • DOMO N/A
  • EPS Growth
  • CDNA N/A
  • DOMO N/A
  • EPS
  • CDNA 1.00
  • DOMO N/A
  • Revenue
  • CDNA $340,826,000.00
  • DOMO $318,363,000.00
  • Revenue This Year
  • CDNA $12.73
  • DOMO $2.32
  • Revenue Next Year
  • CDNA $11.90
  • DOMO $2.72
  • P/E Ratio
  • CDNA $14.81
  • DOMO N/A
  • Revenue Growth
  • CDNA 14.72
  • DOMO N/A
  • 52 Week Low
  • CDNA $10.96
  • DOMO $6.01
  • 52 Week High
  • CDNA $26.37
  • DOMO $18.49
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 48.56
  • DOMO 39.42
  • Support Level
  • CDNA $14.23
  • DOMO $13.52
  • Resistance Level
  • CDNA $15.29
  • DOMO $14.06
  • Average True Range (ATR)
  • CDNA 0.63
  • DOMO 0.52
  • MACD
  • CDNA -0.05
  • DOMO 0.11
  • Stochastic Oscillator
  • CDNA 30.42
  • DOMO 41.67

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

Share on Social Networks: